| abstract |
The present invention relates to a compound of the formula Or a pharmacologically acceptable salt thereof; a pharmaceutical composition comprising a compound of formula (I) in combination with a suitable carrier, diluent or excipient; and physiological disorders, in particular bone mass reduction, There is provided a method of treating osteoporosis, osteopenia or loss of muscle mass or strength comprising administering a compound of formula (I) or a pharmaceutically acceptable salt thereof. |